Zivo Bioscience, Inc. (ZIVOW) — 8-K Filings

8-K Filings (17)

• Zivo Bioscience Reports Director/Officer Changes & Financials — Dec 23, 2025 Risk: medium
  Zivo Bioscience, Inc. filed an 8-K on December 23, 2025, reporting events as of December 19, 2025. The filing covers the departure of directors or certain offic
• Zivo Bioscience Files 8-K — Sep 10, 2025 Risk: low
  Zivo Bioscience, Inc. filed an 8-K on September 10, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, formerly k
• Zivo Bioscience Reports Director, Officer, and Compensation Changes — Aug 18, 2025 Risk: medium
  Zivo Bioscience, Inc. filed an 8-K on August 18, 2025, reporting events as of August 12, 2025. The filing pertains to the departure of directors or certain offi
• Zivo Bioscience Enters Material Definitive Agreement — Jul 14, 2025 Risk: medium
  On July 8, 2025, Zivo Bioscience, Inc. entered into a material definitive agreement related to a financial obligation. The company, formerly known as Health Enh
• Zivo Bioscience Reports on Shareholder Vote Matters — Jun 11, 2025 Risk: medium
  Zivo Bioscience, Inc. filed an 8-K on June 11, 2025, reporting on a submission of matters to a vote of security holders that occurred on June 9, 2025. The compa
• Zivo Bioscience Reports Unregistered Equity Sale — Jan 27, 2025 Risk: medium
  On January 22, 2025, Zivo Bioscience, Inc. reported an unregistered sale of equity securities. The company issued warrants to purchase shares of its common stoc
• Zivo Bioscience Enters Material Definitive Agreement — Jan 15, 2025 Risk: medium
  On January 9, 2025, Zivo Bioscience, Inc. entered into a material definitive agreement. The company, previously known as Health Enhancement Products Inc and Wes
• Zivo Bioscience Files 8-K Report — Jan 7, 2025 Risk: low
  On January 7, 2025, Zivo Bioscience, Inc. filed an 8-K report detailing an "Other Event." The filing does not contain specific financial figures or significant
• Zivo Bioscience Secures New Loan Agreement — Nov 15, 2024 Risk: medium
  On November 12, 2024, Zivo Bioscience, Inc. entered into a material definitive agreement, specifically a loan agreement. This agreement creates a direct financi
• Zivo Bioscience Files 8-K on Equity Sale — Oct 18, 2024 Risk: medium
  On October 17, 2024, Zivo Bioscience, Inc. filed an 8-K report detailing the unregistered sale of equity securities. The company issued warrants to purchase sha
• Zivo Bioscience Announces Board Changes and New CFO — Jul 17, 2024 Risk: medium
  Zivo Bioscience, Inc. announced on July 11, 2024, a series of significant corporate actions including the departure of two directors, the election of two new di
• Zivo Bioscience Reports on Shareholder Vote Matters — Jun 13, 2024 Risk: low
  Zivo Bioscience, Inc. filed an 8-K on June 13, 2024, reporting on a submission of matters to a vote of security holders that occurred on June 11, 2024. The comp
• Zivo Bioscience Files 8-K: Agreements, Personnel Changes — Jun 6, 2024 Risk: medium
  On May 31, 2024, Zivo Bioscience, Inc. entered into a Material Definitive Agreement, the details of which are not fully disclosed in this filing. The company al
• Zivo Bioscience Receives Delisting Notice — Feb 15, 2024 Risk: high
  Zivo Bioscience, Inc. filed an 8-K on February 15, 2024, reporting an event that occurred on February 13, 2024. The filing, under Item Information: Notice of De
• ZIVO Reports Unregistered Equity Sales on Dec 5, 2023 — Jan 17, 2024
  Zivo Bioscience, Inc. (ZIVO) filed an 8-K on January 17, 2024, reporting unregistered sales of equity securities that occurred on December 5, 2023. The filing i
• ZIVO Reports Unregistered Equity Sales on Dec 5, 2023 — Jan 5, 2024
  Zivo Bioscience, Inc. (ZIVO) reported on December 5, 2023, the unregistered sale of equity securities, specifically common stock and warrants. This filing indic
• ZIVO Reports Unregistered Equity Sales on Dec 5, 2203 — Jan 3, 2024
  Zivo Bioscience, Inc. filed an 8-K on January 3, 2024, reporting unregistered sales of equity securities that occurred on December 5, 2023. This filing indicate

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX